UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2020 | 2022-12-15 | Future report Set alerts | |
| Q2 2020 | 2022-08-09 | -0.43 | -0.43 |
| Q1 2020 | 2022-05-10 | 0.00 | 0.00 |
| Q4 2019 | 2022-03-23 | -1.64 | -1.64 |
| Q3 2019 | 2019-11-05 | -1.06 | -1.06 |
| Q2 2019 | 2019-08-07 | -0.33 | -0.33 |
| Q1 2019 | 2019-05-07 | -1.49 | -1.49 |
| Q4 2018 | 2019-02-26 | -1.70 | -1.70 |
| Q3 2018 | 2018-11-07 | -1.58 | -1.58 |
| 2016-06-22 | Reiterated Rating | Needham & Company LLC | Buy | $46.00 |
| 2016-06-02 | Reiterated Rating | Leerink Swann | Buy | $46.00 to $47.00 |
| 2016-06-02 | Boost Price Target | Wedbush | Outperform | $42.00 to $46.00 |
| 2016-06-02 | Boost Price Target | Needham & Company LLC | Buy | $42.00 to $46.00 |
| 2016-05-10 | Reiterated Rating | Leerink Swann | Buy | $39.00 to $46.00 |
| 2016-05-10 | Reiterated Rating | Needham & Company LLC | Buy | $38.00 to $42.00 |
| 2016-04-16 | Reiterated Rating | Leerink Swann | Outperform | |
| 2016-04-01 | Reiterated Rating | Needham & Company LLC | Buy | $38.00 |
| 2016-03-19 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-03-16 | Lower Price Target | Citigroup Inc. | Buy | $42.00 to $40.00 |
| 2016-01-08 | Boost Price Target | Needham & Company LLC | Buy | $33.00 to $38.00 |
| 2015-12-17 | Upgrade | Citigroup Inc. | Neutral to Buy | $20.00 to $42.00 |
| 2015-09-15 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-09-14 | Boost Price Target | Leerink Swann | Outperform | $34.00 to $39.00 |
| 2015-08-19 | Initiated Coverage | Cowen and Company | Outperform | $40.00 |
| 2015-08-17 | Boost Price Target | Needham & Company LLC | Buy | $23.00 to $33.00 |
| 2015-08-07 | Boost Price Target | Guggenheim | Buy | $22.00 to $40.00 |
| 2015-07-13 | Reiterated Rating | Leerink Swann | Outperform | $34.00 |
| 2015-03-26 | Boost Price Target | Leerink Swann | Outperform | $32.00 to $34.00 |
| 2015-02-09 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2014-10-28 | Initiated | Needham | Buy | $23 |
| 2014-10-28 | Initiated Coverage | Leerink Swann | Outperform | $32.00 |
| 2014-10-28 | Initiated Coverage | Guggenheim | Buy | $22.00 |
| 2014-10-28 | Initiated Coverage | Needham & Company LLC | Buy | $23.00 |
| 2014-10-28 | Initiated Coverage | Citigroup Inc. | Buy | $23.00 |
| 2016-06-22 | Reiterated Rating | Needham & Company LLC | Buy | $46.00 |
| 2016-06-02 | Reiterated Rating | Leerink Swann | Buy | $46.00 to $47.00 |
| 2016-06-02 | Boost Price Target | Wedbush | Outperform | $42.00 to $46.00 |
| 2016-06-02 | Boost Price Target | Needham & Company LLC | Buy | $42.00 to $46.00 |
| 2016-05-10 | Reiterated Rating | Leerink Swann | Buy | $39.00 to $46.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In DERM 32 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 1.49M |
| Broadfin Capital, LLC | 0.90M |
| B. Riley Financial, Inc. | 0.86M |
| BlackRock Institutional Trust Company, N.A. | 0.68M |
| BLACKROCK ADVISORS LLC | 0.50M |
| TEACHERS ADVISORS INC | 0.36M |
| Opaleye Management Inc. | 0.26M |
| BlackRock Group LTD | 0.25M |
| PERKINS CAPITAL MANAGEMENT INC | 0.21M |
| AMERICAN FINANCIAL GROUP INC | 0.18M |
| Neuberger Berman Group LLC | 0.16M |
| BlackRock Investment Management, LLC | 0.12M |
| Iguana Healthcare Management, LLC | 100000 |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 75900 |
| BB&T SECURITIES, LLC | 39452 |
UM